School of Medicine
Showing 181-187 of 187 Results
-
Jennifer Elynn Yeh, MD PhD
Clinical Assistant Professor, Dermatology
BioDr. Jennifer E. Yeh, M.D. Ph.D., is a Clinical Assistant Professor of Dermatology at Stanford University School of Medicine. Dr. Yeh graduated Phi Beta Kappa and Tau Beta Pi with a B.S. in chemical & biological engineering from the Massachusetts Institute of Technology. She received her M.D. and Ph.D. from Harvard Medical School, where she studied molecular modulators of the oncogenic transcription factor STAT3 and received the Ruth L. Kirschstein National Research Service Award from the National Cancer Institute. She completed her internship in internal medicine at Brigham and Women’s Hospital followed by Dermatology residency in the Harvard Combined Dermatology Program where she served as Chief Resident during her final year.
Dr. Yeh co-directs a Dermatology-Rheumatology multidisciplinary clinic with a focus on autoimmune connective tissue diseases with Dr. Yashaar Chaichian (Rheumatology). Her clinical interests also include acne, eczema, psoriasis, and skin cancer. She has a special interest in medical education and serves as Co-Director of the Medical Dermatology curriculum for the Stanford Dermatology Residency Program. She also serves as the department's Wellbeing Director, championing initiatives to enhance professional fulfillment and reduce burnout. -
Lisa Zaba, MD, PhD
Associate Professor of Dermatology
BioLisa Zaba M.D. Ph.D., is an Associate Professor of Dermatology, and Director of the Merkel cell carcinoma (MCC) multi-disciplinary clinic and member of the supportive oncodermatology group at the Stanford Cancer Center. She runs a lab focusing on the immunology of MCC and the treatment and prognostic implications of immune checkpoint inhibitor and targeted therapy rashes. Dr. Zaba completed medical school at Cornell University, PhD in immunology at Rockefeller University, Residency and Post-Doc at Stanford University in 2013.
-
Shu Zhang
Postdoctoral Scholar, Dermatology
BioMy research interest is the correlation between tumor heterogeneity and ecDNA, especially related to drug resistance.
